104 related articles for article (PubMed ID: 290264)
1. Recruitment-chemoradiotherapy with VM 26 (epipodophyllotoxin) for induction treatment of malignant brain tumours.
Yamamoto H; Shitara N; Takakura K; Sano K
Acta Neurochir Suppl (Wien); 1979; 28(2):616-8. PubMed ID: 290264
[No Abstract] [Full Text] [Related]
2. Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
Pavone-Macaluso M; Caramia G; Rizzo FP; Messana V
Eur Urol; 1975; 1(1):53-6. PubMed ID: 786645
[TBL] [Abstract][Full Text] [Related]
3. Iv methyl-CCNU, VM-26, and cranial irradiation in therapy for malignant brain tumors.
Gutin PH; Walker MD
Cancer Treat Rep; 1977 Dec; 61(9):1715-7. PubMed ID: 597821
[No Abstract] [Full Text] [Related]
4. VM-26 as a second drug in the treatment of brain gliomas.
Kessinger A; Lemon HM; Foley JF
Cancer Treat Rep; 1979 Mar; 63(3):511-2. PubMed ID: 427830
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy based on a model of cell recruitment by partial synchronization.
Pouillart P; Weiner R; Schwarzenberg L; Misset JL; Oldham R; Amiel JL; Mathé G
Med Pediatr Oncol; 1975; 1(2):123-34. PubMed ID: 1228412
[TBL] [Abstract][Full Text] [Related]
6. Treatment of malignant gliomas in adults using a combination of adriamycine, VM 26 and CCNU: results of a type II trial.
Pouillart P; Mathe G; Thy TH; Lheritier J; Poisson M; Huguenin P; Gautier H; Morin P; Parrot R
Eur J Cancer (1965); 1977; 13(4-5):419-24. PubMed ID: 326555
[No Abstract] [Full Text] [Related]
7. Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.
Grieder A; Maurer R; Stähelin H
Cancer Res; 1977 Sep; 37(9):2998-3005. PubMed ID: 69488
[No Abstract] [Full Text] [Related]
8. Effects of the epipodophyllotoxin derivative VM 26 in mitosis and in interphase.
Stähelin H; Poschmann G
Oncology; 1978; 35(5):217-9. PubMed ID: 103022
[TBL] [Abstract][Full Text] [Related]
9. Teniposide: a review of 12 years of experience.
O'Dwyer PJ; Alonso MT; Leyland-Jones B; Marsoni S
Cancer Treat Rep; 1984 Dec; 68(12):1455-66. PubMed ID: 6391663
[No Abstract] [Full Text] [Related]
10. [Role of VM26 on glioma cells in vitro--analysis of G0 cells and recruitment (author's transl)].
Yamamoto H; Shitara N; Nomura K; Basugi N; Takakura K; Sano K
Neurol Med Chir (Tokyo); 1978 Aug; 18(6):503-13. PubMed ID: 82214
[No Abstract] [Full Text] [Related]
11. [Trial treatment of glioblastomas in adults and cerebral metastais by adriamycin, VM 26 and CCNU combination. Result of a type II trial].
Pouillart P; Mathé G; Poisson M; Buge A; Huguenin P; Gautier H; Morin P; Thy HT; Lheritier J; Parrot R
Nouv Presse Med; 1976 Jun; 5(25):1571-6. PubMed ID: 778798
[TBL] [Abstract][Full Text] [Related]
12. [Surgically treated supratentorial gliomas in the adult. Favourable action of a podophyllin derivative (VM 26) administered alone (author's transl)].
Trouillas P; Chassard JL; Tommasi M; Aimard G; Devic M
Nouv Presse Med; 1978 Dec; 7(44):4017-9. PubMed ID: 733569
[TBL] [Abstract][Full Text] [Related]
13. Malignant gliomas treated after surgery by combination chemotherapy and delayed radiation therapy. Part II. Tolerance to irradiation after chemotherapy.
Poisson M; Hauw JJ; Pouillart P; Bataini JP; Mashaly R; Pertuiset BF; Metzger J
Acta Neurochir (Wien); 1979; 51(1-2):27-42. PubMed ID: 532726
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors.
Seiler RW; Vassella F; Markwalder H
Surg Neurol; 1979 Mar; 11(3):237-42. PubMed ID: 473022
[TBL] [Abstract][Full Text] [Related]
15. VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
Mechl Z; Rovný F; Sopková B
Neoplasma; 1977; 24(4):411-4. PubMed ID: 904743
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of VM-26 in patients with metastatic malignant melanoma.
Bellet RE; Catalno RB; Mastrangelo MJ; Berd D; Koons LS
Cancer Treat Rep; 1978 Mar; 62(3):445-7. PubMed ID: 348313
[No Abstract] [Full Text] [Related]
17. [Synchronization chemoradiotherapy for malignant gliomas].
Yamamoto H; Sato F; Nakamura O; Kohno T; Shitara N; Takakura K; Sano K; Maehara T; Akanuma A
No Shinkei Geka; 1984 Jun; 12(7):795-805. PubMed ID: 6592471
[TBL] [Abstract][Full Text] [Related]
18. Nonresponsiveness of brain tumors to VM-26 therapy in children.
Sullivan MP; van Eys J; Herson J; Starling KA; Ragab A; Sexhauer C
Cancer Treat Rep; 1979 Jan; 63(1):155-6. PubMed ID: 369689
[No Abstract] [Full Text] [Related]
19. Antimetastasis effect of two derivatives of epiposophyllotoxin in mice.
Cattan A; Pourny C; Carpentier Y; Cattan E; Barouh M
Eur J Cancer (1965); 1976 Oct; 12(10):797-805. PubMed ID: 976288
[No Abstract] [Full Text] [Related]
20. Treatment of malignant gliomas and brain metastases in adults using a combination of adriamycine, VM 26, and CCNU. Results of a type II trial.
Pouillart P; Mathé G; Palangie T; Lheritier J; Poisson M; Huguenin P; Gautier H; Morin P; Parrot R
Recent Results Cancer Res; 1977; (62):17-28. PubMed ID: 341249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
